About episil® oral liquid

Available treatment options for oral mucositis are limited, despite the fact that it is a well-known and often serious complication of cancer therapy. As a result of world-class Swedish engineering, episil® oral liquid represents an innovative treatment concept for the intraoral pain associated with oral mucositis. episil® oral liquid is a preservative-free liquid that comes in a convenient, ready-to-use, pocket-sized, multidose device for intraoral administration. episil® liquid provides pain relief via a mechanical barrier that is formed by the lipids (Ref. 8).

episil® liquid is based on award-winning FluidCrystal® technology and contains a patented mixture of phospholipids (soy lecithin) and glycerol dioleate (Ref. 12). After administration, and in contact with small quantities of aqueous fluid present in the oral cavity, the lipid mixture self-assembles to form a robust protective lipid membrane that strongly adheres to the oral mucosa (Ref. 8).

episil® liquid has shown good local and systemic tolerability in clinical and pre-clinical studies (Ref. 8). episil® oral liquid can be swallowed.

Content: Glycerol dioleate, Phosphatidylcholine (soy lecithin), Ethanol, Propylene glycol, Polysorbate 80 and Peppermint oil.

Lipids converge upon saliva and self-assemble to form spheres.
Spheres connect and rapidly transition to a micro-thin gel matrix.
Technologically advanced bioadhesive barrier soothes, coats, and protects.
Download package insert
Clinical data

Why choose episil® oral liquid for the relief of pain caused by oral mucositis

  • Clinically demonstrated rapid pain reduction (Ref. 10, 11)
  • Long-lasting pain relief, for up to 8 hours (Ref. 11)
  • Superior bioadhesion demonstrated in clinical trials (Ref. 8)
  • Lipid-layer protection of sore oral mucosa (Ref. 8)
  • Demonstrated safety with no systemic side effects (Ref. 11)
  • Ready-to-use, pocket-sized, multi-dose device (Ref. 9)
Order episil® oral liquid